GREGoR:加速罕见疾病的基因组学
Moez Dawood1,2,3, Ben Heavner4, Marsha M Wheeler4
1Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA. mdawood@bcm.edu.
Nature
|November 12, 2025
概括
通过应用和标准化基因组技术来加速罕见疾病的诊断. 这项倡议提供了至关重要的数据集,以推进全球尚未解决的罕见疾病病例的遗传诊断.
科学领域:
- 基因组学
- 罕见疾病
- 医学遗传学
背景情况:
- 在全球范围内,每20人中就有1人患有罕见疾病,这给诊断带来了重大挑战.
- 尽管下一代测序技术取得了进展,但仍有超过一半的疑似罕见病例未被诊断.
- 现有的临床遗传检测往往无法在罕见疾病患者中识别引起的遗传变异.
研究的目的:
- 建立一个合作框架来研究具有挑战性的罕见病例.
- 应用,标准化和评估新兴的基因组技术用于罕见疾病诊断.
- 加速对罕见疾病的先进基因组学方法的临床采用.
主要方法:
- 基因组研究以阐明罕见疾病的遗传学 (GREGoR) 联盟研究了成千上万的罕见疾病病例和家族.
- 使用先进的基因组学技术和计算分析来优先考虑基因和变异.
- 通过分析,可视化和信息实验室 (AnVIL) 提供了广泛的临床和遗传数据.
主要成果:
- 来自3000个家庭的7500多个个体的综合基因组数据集.
- 确定了以前未解决的罕见疾病病例的潜在遗传诊断.
- 建立了罕见疾病基因组研究的基础资源.
结论:
- GREGoR联盟提供关键资源和数据集,以推进罕见疾病的诊断.
- 标准化基因组技术和数据共享是解决难以解决的罕见疾病问题的关键.
- 这项倡议促使全球努力改善罕见疾病的遗传诊断.
更多相关视频
07:43An Enzyme- and Serum-free Neural Stem Cell Culture Model for EMT Investigation Suited for Drug Discovery
Published on: August 23, 2016
10.4K
08:38Author Spotlight: A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition
Published on: July 21, 2023
1.6K
相关概念视频
Genomics
35.5K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
35.5K
Animal Mitochondrial Genetics
7.8K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
7.8K
Genetic Screens
4.6K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
4.6K
Genome-wide Association Studies-GWAS
12.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.6K
Pharmacogenetics and Pharmacogenomics: Overview
253
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
253
Pharmacogenomics: Identification of New Drug Targets
121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
